ABOUT US
Dreampac Corp makes the technology of dreams coming true
History
Company History
2026
Development of DreamSeal(DS002), DreamOnePort(DO002), DreamLine(DL002)
2025
Patent application filed for a surgical retriever to prevent intra-abdominal gas leakage
Development of DreamPen (DP003, 5mm)
World’s first certification of a dedicated injector for PIPAC
Designation as an Innovative Medical Device and approval of new medical technology
Patent application filed for tumor phenotypes and biomarkers for prognosis prediction in advanced ovarian cancer
2024
Development of DreamLine (DL001), DreamPen (DP002, 8mm)
2023
Development of DreamSeal (DS001)
Patent application filed for a position-adjustable drug delivery device
Patent application filed for CA-125 preconditioning prior to first-line chemotherapy
2022
Initiated medical device certification process
Grand Prize, 8th Wonju Medical Device Techno Valley Public Contest
Top Excellence Award, 3rd Bio Venture Competition by the Mirae Medical Research Foundation
GMP manufacturer certification obtained
Development of DreamPen (DP001, 10mm), DreamCover (DC001), DreamOnePort (DO001)
2021
3rd animal study completed
Nozzle and Rotator Device testing completed
2020
1st and 2nd injection tests completed
Anticancer drug injection testing through large-animal studies
2nd animal study completed
Anticancer pump pressure testing completed
2018
1st animal study completed
Anticancer drug external leakage test and abdominal wall airtightness test
2017
- RIPAC Kick-Off Meeting